Product
Dihydroartemisinin
4 clinical trials
5 indications
Indication
MalariaIndication
VivaxIndication
InfectionsIndication
Plasmodium FalciparumIndication
Polycystic Ovary SyndromeClinical trial
Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West PapuaStatus: Completed, Estimated PCD: 2019-04-16
Clinical trial
Effectiveness of Momordica Charantia Extract Compared to the Standard Antimalarial Drug Combination Dihydroartemisinin Piperaquine-primaquine in Patients With Uncomplicated Falciparum Malaria, in Sumba Barat Daya District of IndonesiaStatus: Completed, Estimated PCD: 2022-12-31
Clinical trial
The Evaluation of the Effect of Dihydroartemisinin in Patients With Polycystic Ovary SyndromeStatus: Completed, Estimated PCD: 2023-03-23
Clinical trial
Therapeutic Efficacy of Dihydroartemisinin in Patients With Polycystic Ovary SyndromeStatus: Recruiting, Estimated PCD: 2025-03-01